resveratrol has been researched along with cyclin d1 in 35 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (2.86) | 18.2507 |
| 2000's | 9 (25.71) | 29.6817 |
| 2010's | 20 (57.14) | 24.3611 |
| 2020's | 5 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Lin, JK; Tsai, SH | 1 |
| Adhami, VM; Afaq, F; Ahmad, N; Feyes, DK; Mukhtar, H | 1 |
| Akoglu, B; Clausnitzer, A; Stein, J; Wolter, F | 1 |
| Joe, AK; Liu, H; Suzui, M; Vural, ME; Weinstein, IB; Xiao, D | 1 |
| Pan, CE; Sun, ZJ; Wu, SL; Yu, L | 1 |
| Carter, B; Cilenti, L; Jove, R; Khaled, A; Kotha, A; Sekharam, M; Siddiquee, K; Turkson, J; Zervos, AS | 1 |
| Abboud, HE; Choudhury, GG; Das, F; Ghosh-Choudhury, N; Kamat, A; Kasinath, BS; Mahimainathan, L; Venkatesan, B | 1 |
| Narayanan, BA; Narayanan, NK; Nargi, D; Randolph, C | 1 |
| Feng, X; Lin, N; Liu, H; Luo, Z; Wang, J; Xu, X; Zhang, B | 1 |
| Al-Holou, S; Chopp, M; Gautam, SC; Jiang, H; Kuo, J; Li, C; Shang, X; Wu, H; Zhang, L | 1 |
| Motiwale, L; Naik, N; Parekh, P; Rao, KV | 1 |
| Radhakrishnan, S; Reddivari, L; Tarver, C; Vanamala, J | 1 |
| Chatterjee, M; Das, S; Janarthan, M; Ramachandran, HK | 1 |
| Alberti, S; De Domenico, S; Del Boccio, P; Leporatti, S; Maffia, M; Pieragostino, D; Salzet, M; Santino, A; Simeone, P; Tinelli, A; Toraldo, D; Urbani, A; Vergara, D; Vergaro, V | 1 |
| Hsieh, TC; Lee, YS; Lin, CY; Wu, JM; Yang, CJ | 1 |
| Ban, JO; Cho, MK; Hong, JT; Lee, KA; Lee, SH; Lee, YJ; Nam, HS; Shim, JH | 1 |
| Cho, MK; Choi, YJ; Im, JH; Kim, YB; Lee, SH; Lee, YJ; Nam, HS; Won, SY | 1 |
| Carew, MA; Carrington, S; Meira, LB; Modjtahedi, H; Polycarpou, E; Tyrrell, E | 1 |
| Choi, DW; Choi, KC; Hwang, KA; Kang, NH; Lee, HR | 1 |
| Rössler, OG; Thiel, G | 1 |
| Chen, N; Li, M; Liu, B; Liu, J; Xia, J; Zhang, Q; Zhou, W; Zhou, Z; Zhu, R | 1 |
| Bhat, HK; Bhat, NK; Chatterjee, A; Dandawate, P; Murphy, L; Padhye, S; Ronghe, A; Singh, B | 1 |
| Holcombe, RF; Martinez, M; Planutiene, M; Planutis, K | 1 |
| Chen, XY; Kong, QY; Li, C; Li, H; Liu, J; Wu, ML; Yang, B; Yao, YY; Zhang, P; Zhong, LX | 1 |
| Arechaga Ocampo, E; García Mena, J; Gariglio, P; López-Camarillo, C; Marchat, LA; Martínez Castillo, M; Medina-Aguilar, R; Villegas Sepúlveda, N | 1 |
| Cho, S; Kim, JR; Lim, J; Park, S | 1 |
| Chen, J; Fei, DD; Hu, CH; Huang, WT; Jin, Y; Liu, N; Lu, YB; Lv, YJ; Pang, DL; Sui, BD; Xuan, K; Zhao, P; Zheng, CX; Zhou, CH | 1 |
| Chen, X; Xu, S; Ying, Y; Zhou, R; Zhou, W | 1 |
| Bao, X; Chen, C; Chen, S; Chen, T; Guo, W; Li, Y; Ren, B; Tang, B; Wang, D; Wang, H; Wang, W; Wang, Y; Yang, Q; Zhang, L | 1 |
| Aires, V; Delmas, D; Martiny, L; Nivelle, L; Rioult, D; Tarpin, M | 1 |
| Ansary, J; Battino, M; Chen, R; Cianciosi, D; Forbes-Hernandez, TY; Giampieri, F; Gil, E; Liu, S; Yang, HZ; Zeng, J; Zhang, F; Zhang, J; Zhou, F | 1 |
| Changou, CA; Chen, YR; Chin, YT; Chiu, HC; Crawford, DR; Davis, PJ; Ho, Y; Huang, TY; Lee, SY; Li, ZL; Lin, HY; Mousa, SA; Pan, YS; Shih, YJ; Su, KW; Su, PY; Wang, K; Whang-Peng, J; Wu, CY; Yang, YSH | 1 |
| Huang, JA; Jiang, JH; Liu, YY; Wang, CG; Zeng, DX; Zhang, WY | 1 |
| Gui, LI; Hou, J; Liu, X; Tao, J; Wang, J; Yang, P; Yao, Y; Yu, M; Zhang, Y | 1 |
| Cao, Z; Li, H; Li, L; Su, N; Wu, S; Zhou, E | 1 |
1 review(s) available for resveratrol and cyclin d1
| Article | Year |
|---|---|
Chemoprevention of cancer and cardiovascular disease by resveratrol.
Topics: Anticarcinogenic Agents; Carcinogens; Cardiovascular Diseases; Cell Cycle; Cyclin D1; Enzyme Inhibitors; Gene Expression Regulation; Growth Substances; Humans; Lipid Peroxidation; Neoplasms; NF-kappa B; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Oxidative Stress; Phosphorylation; Protein Processing, Post-Translational; Reactive Oxygen Species; Receptor Protein-Tyrosine Kinases; Resveratrol; Risk Factors; Rosales; Signal Transduction; Stilbenes; Transcription, Genetic; Wine | 1999 |
34 other study(ies) available for resveratrol and cyclin d1
| Article | Year |
|---|---|
Resveratrol causes WAF-1/p21-mediated G(1)-phase arrest of cell cycle and induction of apoptosis in human epidermoid carcinoma A431 cells.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Carcinoma, Squamous Cell; CDC2-CDC28 Kinases; Cell Division; Cyclin D1; Cyclin D2; Cyclin E; Cyclin-Dependent Kinase 2; Cyclin-Dependent Kinase 4; Cyclin-Dependent Kinase 6; Cyclin-Dependent Kinase Inhibitor p21; Cyclin-Dependent Kinases; Cyclins; G1 Phase; Humans; Phosphotransferases; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; Resveratrol; Stilbenes; Tumor Cells, Cultured | 2001 |
Downregulation of the cyclin D1/Cdk4 complex occurs during resveratrol-induced cell cycle arrest in colon cancer cell lines.
Topics: Alkaline Phosphatase; Anticarcinogenic Agents; Apoptosis; Caco-2 Cells; Caspase 3; Caspases; Cell Cycle; Cyclin D1; Cyclin-Dependent Kinase 4; Cyclin-Dependent Kinases; Dose-Response Relationship, Drug; Down-Regulation; Flow Cytometry; G2 Phase; Humans; Immunoblotting; Proto-Oncogene Proteins; Resveratrol; S Phase; Stilbenes; Tumor Cells, Cultured | 2001 |
Resveratrol induces growth inhibition, S-phase arrest, apoptosis, and changes in biomarker expression in several human cancer cell lines.
Topics: Anticarcinogenic Agents; Apoptosis; Biomarkers, Tumor; Cell Cycle; Cell Division; Cyclin D1; Cyclins; DNA Primers; Dose-Response Relationship, Drug; Flow Cytometry; Humans; Immunoblotting; Luciferases; Resveratrol; Reverse Transcriptase Polymerase Chain Reaction; Ribonucleotide Reductases; RNA, Messenger; RNA, Neoplasm; S Phase; Stilbenes; Tumor Cells, Cultured | 2002 |
Effect of resveratrol on cell cycle proteins in murine transplantable liver cancer.
Topics: Animals; Antineoplastic Agents, Phytogenic; CDC2 Protein Kinase; Cell Cycle Proteins; Cyclin B; Cyclin B1; Cyclin D1; Liver Neoplasms; Mice; Mice, Inbred BALB C; Neoplasm Transplantation; Resveratrol; Stilbenes | 2003 |
Resveratrol inhibits Src and Stat3 signaling and induces the apoptosis of malignant cells containing activated Stat3 protein.
Topics: Animals; Antineoplastic Agents, Phytogenic; Apoptosis; bcl-X Protein; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cyclin D1; Female; Gene Expression; Humans; Male; Mice; Myeloid Cell Leukemia Sequence 1 Protein; Neoplasm Proteins; Neoplasms; Proto-Oncogene Proteins c-bcl-2; Resveratrol; Signal Transduction; src-Family Kinases; STAT3 Transcription Factor; Stilbenes | 2006 |
Resveratrol inhibits PDGF receptor mitogenic signaling in mesangial cells: role of PTP1B.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Antioxidants; Cell Line; CSK Tyrosine-Protein Kinase; Cyclin D1; Cyclin-Dependent Kinase 2; DNA Replication; Humans; Inhibitory Concentration 50; Mesangial Cells; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Phosphoinositide-3 Kinase Inhibitors; Phosphorylation; Protein Tyrosine Phosphatase, Non-Receptor Type 1; Protein-Tyrosine Kinases; Proto-Oncogene Proteins c-akt; Rats; Receptors, Platelet-Derived Growth Factor; Resveratrol; Retinoblastoma Protein; Signal Transduction; Sirtuin 1; Sirtuins; src-Family Kinases; Stilbenes | 2008 |
Liposome encapsulation of curcumin and resveratrol in combination reduces prostate cancer incidence in PTEN knockout mice.
Topics: Androgen Receptor Antagonists; Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Blotting, Western; Carrier Proteins; Cell Cycle; Cell Proliferation; Curcumin; Cyclin D1; Disease Progression; Drug Carriers; Drug Delivery Systems; Incidence; Liposomes; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Phosphotransferases (Alcohol Group Acceptor); Prostatic Neoplasms; Proto-Oncogene Proteins c-akt; PTEN Phosphohydrolase; Receptors, Androgen; Resveratrol; Signal Transduction; Stilbenes; TOR Serine-Threonine Kinases | 2009 |
[Suppressive effect of resveratrol on growth of U251 human glioma cells and its correlated mechanism].
Topics: Apoptosis; bcl-2-Associated X Protein; bcl-X Protein; Blotting, Western; Caspase 3; Cell Line, Tumor; Cyclin D1; Gene Expression Regulation, Neoplastic; Glioma; Humans; Immunohistochemistry; Proto-Oncogene Proteins c-bcl-2; Resveratrol; STAT3 Transcription Factor; Stilbenes | 2009 |
Resveratrol downregulates PI3K/Akt/mTOR signaling pathways in human U251 glioma cells.
Topics: Antineoplastic Agents, Phytogenic; Caspase 3; Cell Line, Tumor; Cyclin D1; Dose-Response Relationship, Drug; Down-Regulation; Glioma; Humans; Phosphoinositide-3 Kinase Inhibitors; Protein Kinases; Proto-Oncogene Proteins c-akt; Resveratrol; Signal Transduction; Stilbenes; TOR Serine-Threonine Kinases | 2009 |
Downregulation of cyclin D1 is associated with decreased levels of p38 MAP kinases, Akt/PKB and Pak1 during chemopreventive effects of resveratrol in liver cancer cells.
Topics: Anticarcinogenic Agents; Blotting, Western; Cell Proliferation; Cell Survival; Cyclin D1; Down-Regulation; Flow Cytometry; Hep G2 Cells; Humans; Liver; Liver Neoplasms; Microscopy, Confocal; p21-Activated Kinases; p38 Mitogen-Activated Protein Kinases; Proto-Oncogene Proteins c-akt; Resveratrol; Signal Transduction; Stilbenes | 2011 |
Resveratrol suppresses IGF-1 induced human colon cancer cell proliferation and elevates apoptosis via suppression of IGF-1R/Wnt and activation of p53 signaling pathways.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Cell Cycle; Cell Proliferation; Colonic Neoplasms; Cyclin D1; Cyclin-Dependent Kinase Inhibitor p27; Dose-Response Relationship, Drug; Forkhead Box Protein O3; Forkhead Transcription Factors; HT29 Cells; Humans; Insulin-Like Growth Factor I; Intracellular Signaling Peptides and Proteins; Proto-Oncogene Proteins c-akt; Receptor, IGF Type 1; Resveratrol; RNA Interference; Signal Transduction; Stilbenes; Time Factors; Tumor Suppressor Protein p53; Wnt Proteins | 2010 |
Role of 5-lipoxygenase in resveratrol mediated suppression of 7,12-dimethylbenz(α)anthracene-induced mammary carcinogenesis in rats.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Apoptosis; Arachidonate 5-Lipoxygenase; Cell Proliferation; Cyclin D1; DNA Breaks; Female; Gene Expression Regulation, Neoplastic; In Situ Nick-End Labeling; Leukotriene B4; Lipid Peroxidation; Lipoxygenase Inhibitors; Mammary Glands, Animal; Mammary Neoplasms, Experimental; NF-kappa B; Rats; Rats, Sprague-Dawley; Resveratrol; Stilbenes; Transforming Growth Factor beta1 | 2011 |
Resveratrol downregulates Akt/GSK and ERK signalling pathways in OVCAR-3 ovarian cancer cells.
Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Cyclin D1; Down-Regulation; Extracellular Signal-Regulated MAP Kinases; Female; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Humans; Microscopy, Confocal; Ovarian Neoplasms; Phosphatidylinositol 3-Kinases; Phosphorylation; Proteomics; Proto-Oncogene Proteins c-akt; Resveratrol; Signal Transduction; Stilbenes | 2012 |
Control of stability of cyclin D1 by quinone reductase 2 in CWR22Rv1 prostate cancer cells.
Topics: Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cyclin D1; Gene Expression Regulation, Neoplastic; Glycogen Synthase Kinase 3; Humans; Male; Phosphorylation; Prostatic Neoplasms; Proteasome Endopeptidase Complex; Proto-Oncogene Proteins c-akt; Quinone Reductases; Resveratrol; Retinoblastoma Protein; RNA Interference; RNA, Small Interfering; Stilbenes | 2012 |
The flavonoid resveratrol suppresses growth of human malignant pleural mesothelioma cells through direct inhibition of specificity protein 1.
Topics: Animals; Apoptosis; Apoptosis Regulatory Proteins; bcl-2-Associated X Protein; Bcl-2-Like Protein 11; bcl-X Protein; BH3 Interacting Domain Death Agonist Protein; Caspase 3; Cell Line, Tumor; Cyclin D1; Cyclin-Dependent Kinase Inhibitor p21; Cyclin-Dependent Kinase Inhibitor p27; Humans; Inhibitor of Apoptosis Proteins; Membrane Proteins; Mesothelioma; Mice; Mice, Inbred BALB C; Mice, Nude; Myeloid Cell Leukemia Sequence 1 Protein; Pleural Neoplasms; Poly(ADP-ribose) Polymerases; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-bcl-2; Resveratrol; RNA, Messenger; Sp1 Transcription Factor; Stilbenes; Survivin; Transplantation, Heterologous | 2012 |
Synergistic anti-cancer effects of resveratrol and chemotherapeutic agent clofarabine against human malignant mesothelioma MSTO-211H cells.
Topics: Adenine Nucleotides; Antineoplastic Combined Chemotherapy Protocols; Arabinonucleosides; Cell Line, Tumor; Cell Proliferation; Chromones; Clofarabine; Cyclin D1; Enzyme Inhibitors; Epithelial Cells; Humans; Mesothelioma; Morpholines; Phosphoinositide-3 Kinase Inhibitors; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins c-met; Resveratrol; Sp1 Transcription Factor; Stilbenes | 2013 |
Resveratrol 3-O-D-glucuronide and resveratrol 4'-O-D-glucuronide inhibit colon cancer cell growth: evidence for a role of A3 adenosine receptors, cyclin D1 depletion, and G1 cell cycle arrest.
Topics: Adenosine A3 Receptor Antagonists; AMP-Activated Protein Kinases; Apoptosis; Caco-2 Cells; Cell Line, Tumor; Cell Proliferation; Cell Survival; Colonic Neoplasms; Cyclin D1; G1 Phase Cell Cycle Checkpoints; Glucuronides; Hemolysis; Humans; Receptor, Adenosine A3; Resveratrol; Stilbenes | 2013 |
Resveratrol regulates the cell viability promoted by 17β-estradiol or bisphenol A via down-regulation of the cross-talk between estrogen receptor α and insulin growth factor-1 receptor in BG-1 ovarian cancer cells.
Topics: Antineoplastic Agents, Phytogenic; Benzhydryl Compounds; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cyclin D1; Down-Regulation; Estradiol; Estrogen Receptor alpha; Estrogens, Non-Steroidal; Female; Gene Expression Regulation, Neoplastic; Humans; Insulin Receptor Substrate Proteins; Neoplasm Proteins; Ovarian Neoplasms; Phenols; Phosphorylation; Phytoestrogens; Protein Processing, Post-Translational; Receptor, IGF Type 1; Resveratrol; Signal Transduction; Stilbenes | 2013 |
Resveratrol stimulates AP-1-regulated gene transcription.
Topics: Cyclin D1; Dual Specificity Phosphatase 1; Gene Expression Regulation; HEK293 Cells; Hep G2 Cells; Humans; Mitogen-Activated Protein Kinases; Promoter Regions, Genetic; Protein Kinase C; Proto-Oncogene Proteins c-fos; Proto-Oncogene Proteins c-jun; Resveratrol; Stilbenes; Tetradecanoylphorbol Acetate; Transcription Factor AP-1; Transcription, Genetic; Tumor Necrosis Factor-alpha; Up-Regulation | 2014 |
Resveratrol inhibits proliferation in human colorectal carcinoma cells by inducing G1/S‑phase cell cycle arrest and apoptosis through caspase/cyclin‑CDK pathways.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Caco-2 Cells; Caspase 7; Caspase 9; Caspases; Cell Proliferation; Cyclin D1; Cyclin-Dependent Kinase 2; Cyclin-Dependent Kinase 4; Cyclin-Dependent Kinase Inhibitor p21; Cyclin-Dependent Kinases; G1 Phase Cell Cycle Checkpoints; HCT116 Cells; Humans; Poly(ADP-ribose) Polymerases; Proliferating Cell Nuclear Antigen; Resveratrol; S Phase Cell Cycle Checkpoints; Stilbenes | 2014 |
Differential regulation of estrogen receptors α and β by 4-(E)-{(4-hydroxyphenylimino)-methylbenzene,1,2-diol}, a novel resveratrol analog.
Topics: Antineoplastic Agents; Catechols; Cell Line; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cyclin D1; Estrogen Receptor alpha; Estrogen Receptor beta; Humans; Molecular Docking Simulation; para-Aminobenzoates; Proto-Oncogene Proteins c-myc; Resveratrol; RNA, Messenger; Schiff Bases; Stilbenes | 2014 |
Effects of a grape-supplemented diet on proliferation and Wnt signaling in the colonic mucosa are greatest for those over age 50 and with high arginine consumption.
Topics: AC133 Antigen; Adolescent; Adult; Antigens, CD; Arginine; Axin Protein; Biomarkers; Body Mass Index; Cell Proliferation; Colon; Colonic Neoplasms; Cyclin D1; Diet; Female; Glycoproteins; Humans; Intestinal Mucosa; Linear Models; Male; Mental Recall; Middle Aged; Peptides; Proto-Oncogene Proteins c-myc; Resveratrol; Stilbenes; Vitis; Wnt Signaling Pathway; Young Adult | 2015 |
PIAS3, SHP2 and SOCS3 Expression patterns in Cervical Cancers: Relevance with activation and resveratrol-caused inactivation of STAT3 signaling.
Topics: Adenocarcinoma; Antineoplastic Agents, Phytogenic; Carcinoma, Squamous Cell; Cell Proliferation; Cell Survival; Cyclin D1; Female; Gene Expression; HeLa Cells; Humans; Inhibitor of Apoptosis Proteins; Molecular Chaperones; Phosphorylation; Protein Inhibitors of Activated STAT; Protein Tyrosine Phosphatase, Non-Receptor Type 11; Proto-Oncogene Proteins c-myc; Resveratrol; RNA, Neoplasm; Signal Transduction; STAT3 Transcription Factor; Stilbenes; Suppressor of Cytokine Signaling 3 Protein; Suppressor of Cytokine Signaling Proteins; Survivin; Uterine Cervical Neoplasms; Vascular Endothelial Growth Factor A | 2015 |
Resveratrol inhibits cell cycle progression by targeting Aurora kinase A and Polo-like kinase 1 in breast cancer cells.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Aurora Kinase A; BRCA1 Protein; Breast Neoplasms; Cell Cycle Proteins; Cell Line, Tumor; Cell Movement; Cyclin B1; Cyclin D1; Female; G1 Phase Cell Cycle Checkpoints; Humans; MCF-7 Cells; Oligonucleotide Array Sequence Analysis; Polo-Like Kinase 1; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; Resveratrol; Stilbenes; Transcriptome | 2016 |
Inhibitory effects of resveratrol on hepatitis B virus X protein-induced hepatocellular carcinoma.
Topics: Animals; Anticarcinogenic Agents; Antineoplastic Agents, Phytogenic; Cell Line, Tumor; Cyclin D1; Hepatitis B virus; Humans; Inhibitor of Apoptosis Proteins; Liver Neoplasms; Mice, Inbred BALB C; Mice, Nude; Neoplasms, Experimental; Repressor Proteins; Resveratrol; Signal Transduction; STAT3 Transcription Factor; Stilbenes; Survivin; Trans-Activators; Viral Regulatory and Accessory Proteins | 2017 |
Anti-aging pharmacology in cutaneous wound healing: effects of metformin, resveratrol, and rapamycin by local application.
Topics: Acetyl-CoA Carboxylase; Administration, Cutaneous; Aging; AMP-Activated Protein Kinases; Animals; Cyclin D1; Cyclin-Dependent Kinase Inhibitor p16; Enzyme Activation; Female; Gene Expression Regulation; Metformin; Mice; Neovascularization, Physiologic; Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha; Rats; Rats, Sprague-Dawley; Resveratrol; Ribosomal Protein S6 Kinases; Sirolimus; Skin; Skin Aging; Stilbenes; Tumor Suppressor Protein p53; Wound Healing; Wounds, Nonpenetrating | 2017 |
Resveratrol Suppresses Growth and Migration of Myelodysplastic Cells by Inhibiting the Expression of Elevated Cyclin D1 (CCND1).
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Case-Control Studies; Cell Cycle; Cell Movement; Cell Proliferation; Cyclin D1; Gene Expression Regulation; Humans; Myelodysplastic Syndromes; Resveratrol; Stilbenes; Tumor Cells, Cultured | 2017 |
Anticancer Effects of Resveratrol-Loaded Solid Lipid Nanoparticles on Human Breast Cancer Cells.
Topics: Apoptosis Regulatory Proteins; bcl-2-Associated X Protein; Breast Neoplasms; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cyclin D1; Female; Gene Expression Regulation, Neoplastic; Humans; Lipids; Nanoparticles; Particle Size; Proto-Oncogene Proteins c-bcl-2; Proto-Oncogene Proteins c-myc; Resveratrol; Stilbenes | 2017 |
Molecular analysis of differential antiproliferative activity of resveratrol, epsilon viniferin and labruscol on melanoma cells and normal dermal cells.
Topics: Anticarcinogenic Agents; Benzofurans; CDC2 Protein Kinase; Cell Line, Tumor; Cell Proliferation; Cyclin A; Cyclin D1; Cyclin E; Cyclin-Dependent Kinase 2; Fibroblasts; Humans; Melanoma; Resveratrol; S Phase; Skin; Stilbenes; Vitis | 2018 |
Resveratrol inhibits the proliferation of melanoma cells by modulating cell cycle.
Topics: Apoptosis; Cell Cycle; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cyclin D1; Humans; Melanoma; Resveratrol | 2020 |
NDAT suppresses pro-inflammatory gene expression to enhance resveratrol-induced anti-proliferation in oral cancer cells.
Topics: B7-H1 Antigen; Cell Line, Tumor; Cell Proliferation; Cyclin D1; Cyclooxygenase 2; Drug Synergism; Gene Expression; Humans; Mouth Neoplasms; Polyglactin 910; Resveratrol; STAT3 Transcription Factor; Thyroxine | 2020 |
Resveratrol prevented experimental pulmonary vascular remodeling via miR-638 regulating NR4A3/cyclin D1 pathway.
Topics: Animals; Cell Proliferation; Cells, Cultured; Cyclin D1; Disease Models, Animal; DNA-Binding Proteins; Hypertension, Pulmonary; Male; MicroRNAs; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Nerve Tissue Proteins; Pulmonary Artery; Rats, Wistar; Resveratrol; Signal Transduction; Vascular Remodeling | 2020 |
Resveratrol induces proliferation in preosteoblast cell MC3T3-E1 via GATA-1 activating autophagy.
Topics: AMP-Activated Protein Kinases; Animals; Autophagy; Autophagy-Related Protein 7; Cell Differentiation; Cell Line; Cell Nucleus; Cell Proliferation; Cell Survival; Cyclin D1; GATA1 Transcription Factor; Gene Expression Regulation; Mice; Microtubule-Associated Proteins; Osteoblasts; Osteogenesis; Phosphorylation; Protein Transport; Resveratrol; RNA, Small Interfering; Signal Transduction | 2021 |
Resveratrol Downregulates miR-155-5p to Block the Malignant Behavior of Gastric Cancer Cells.
Topics: Caspase 3; Cell Line, Tumor; Cell Proliferation; Claudin-1; Cyclin D1; Gene Expression Regulation, Neoplastic; Humans; MicroRNAs; Proto-Oncogene Proteins c-bcl-2; Resveratrol; Stomach Neoplasms | 2022 |